NEW YORK – Swedish medtech company Capitainer announced on Thursday that it has raised $5.7 million in an investment round to expand and commercialize its self-sampling technology.
The round was led by venture capital firm Sciety and its network Sciety Venture Partners, which has invested in the company three times since 2019, Capitainer said in a statement. The firm's technology allows patients to use a card to collect blood samples that can then be sent through standard mail without a need for refrigeration or special packaging.
The new funding will be used to increase production capacity, develop new products, and intensify sales and marketing efforts, the company added.
"We are confident that our self-sampling technology will become a game-changer in the healthcare industry, providing patients with greater convenience and accessibility while ensuring precise results," Capitainer CEO Christopher Aulin said in a statement.
The firm previously raised SEK 31 million in 2021 in a separate round led by Sciety.